Abiopharma

New Form DEFA14A - EXACT SCIENCES CORP Filed: 2026-01-23 AccNo: 0001193125-26-020096 Size: 20 KB

New Form 424B5 - Corvus Pharmaceuticals, Inc. Filed: 2026-01-23 AccNo: 0001104659-26-005967 Size: 1 MB

New Form SCHEDULE 13G/A - Sharps Technology Inc. Filed: 2026-01-23 AccNo: 0001062993-26-000395 Size: 11 KB

DEFA14A (Additional Proxy Soliciting Materials (definitive)) SEC Filing

Equity Listing - Ordinary Shares: Issue and Allotment of Shares Pursuant to Exercise of Warrants

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Mandatory Cash Dividend/ Distribution:

Statement from Fresenius Medical Care on Upcoming Winter Storm

GH Research PLC (GHRS) Files Form 6-K

I-Mab (IMAB) Files Form 6-K

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology

ResMed Inc. Daily Stock Update

New Zynex Leadership Responds to Indictment of Former Executives